William Blair

NexPhase Capital Announces Sale of FAST to Verisk | PR Newswire | 12/4/2019

NEW YORK NexPhase Capital, LP (“NexPhase” or the “Firm”), an operationally focused private equity firm and sub-advisor to the Moelis Capital Partners (“MCP”) Opportunity Funds, today announced that it has entered into a definitive agreement to sell Flexible Architecture & Simplified Technology, LLC (“FAST” or the “Company”), a leading software company for the life insurance and annuity industry, to Verisk Analytics, Inc. (“Verisk”). Founded in 2010, FAST is a leader …

General Electric (NYSE:GE) Given a $11.00 Price Target by Credit Suisse Group Analysts - TheOlympiaReport | 12/4/2019

… Friday, October 4th. Morgan Stanley initiated coverage on shares of General Electric in a research report on Thursday, September 5th. They issued an equal weight rating and a $10.00 price objective for the company. William Blair reaffirmed a buy rating on shares of General Electric in a research report on Friday, August 16th. Finally, JPMorgan Chase & Co. set a $5.00 price objective on General Electric and gave the stock an …

Follow William Blair:    

General Electric’s (GE) “Buy” Rating Reiterated at William Blair | 12/4/2019

General Electric’s (GE) “Buy” Rating Reiterated at William Blair Posted by Bonnie Powley on Dec 4th, 2019 Tweet General Electric (NYSE:GE) ‘s stock had its “buy” rating reaffirmed by analysts at William Blair in a research note issued on Tuesday, TipRanks reports. Several other research firms have also issued reports on GE. Morgan Stanley initiated coverage on General Electric in a research note on Thursday, September 5th. They set …

William Blair Reiterates “Buy” Rating for General Electric (NYSE:GE) | Daily Political | 12/4/2019

General Electric (NYSE:GE) ‘s stock had its “buy” rating restated by equities researchers at William Blair in a note issued to investors on Tuesday, TipRanks reports.GE has been the topic of a number of other research reports. Zacks Investment Research raised shares of General Electric from a “sell” rating to a “hold” rating and set a $10.00 price objective on the stock in a report on Friday, November 1st …

Henry Schein (NASDAQ:HSIC) Price Target Raised to $71.00 at Bank of America - TheOlympiaReport | 12/4/2019

… gave the stock an overweight rating in a research report on Monday, November 11th. Cleveland Research reaffirmed a hold rating on shares of Henry Schein in a research report on Friday, November 1st. Finally, William Blair downgraded shares of Henry Schein from an outperform rating to a market perform rating in a report on Wednesday, August 7th. Four research analysts have rated the stock with a sell rating, nine have …

Stock Analysts’ Updated EPS Estimates for December, 4th (ALIM, APDN, AVNW, BOLD, CDTX, CHGG, CRM, DENN, DRI, ENB) | 12/4/2019

… CRM) had its buy rating reiterated by analysts at Oppenheimer Holdings Inc.. The firm currently has a $190.00 target price on the stock. salesforce.com (NYSE:CRM) had its outperform rating reiterated by analysts at William Blair . salesforce.com (NYSE:CRM) had its buy rating reiterated by analysts at Cowen Inc. The firm currently has a $195.00 price target on the stock. Denny’s (NASDAQ:DENN) was upgraded by analysts at Maxim Group …

Huron Consulting Group (NASDAQ:HURN) Sets New 12-Month High at $68.71 - Stock Observer | 12/4/2019

… objective for the company in a research note on Thursday, October 31st. ValuEngine downgraded Huron Consulting Group from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Finally, William Blair reiterated an “outperform” rating on shares of Huron Consulting Group in a report on Thursday, September 12th. Two analysts have rated the stock with a hold rating and five have issued a buy rating …

Amgen (NASDAQ:AMGN) Sets New 1-Year High at $236.00 | Daily Political | 12/4/2019

… 6987 shares traded. The stock $234.72.AMGN has been the subject of several recent analyst reports. Evercore ISI reissued a “hold” rating on shares of Amgen in a research note on Sunday, August 11th. William Blair reaffirmed a “hold” rating on shares of Amgen in a research note on Friday, August 30th. Oppenheimer set a $240.00 price target on shares of Amgen and gave the company a “buy” rating in …

General Electric (NYSE:GE) Earns Buy Rating from William Blair | 12/4/2019

Posted by ABMN Staff on Dec 4th, 2019 // No Comments General Electric (NYSE:GE) ‘s stock had its “buy” rating reiterated by equities research analysts at William Blair in a report released on Tuesday, TipRanks reports. A number of other analysts also recently weighed in on the stock. Deutsche Bank increased their target price on shares of General Electric from $11.00 to $12.00 and gave the company a “hold” rating …

Voloridge Investment Management LLC Takes $2.50 Million Position in BJs Wholesale Club Holdings Inc (NYSE:BJ) | 12/4/2019

… position in BJs Wholesale Club by 17.1% during the 2nd quarter. Vanguard Group Inc. now owns 12,142,930 shares of the company’s stock worth $320,574,000 after purchasing an additional 1,774,604 shares during the last quarter. William Blair Investment Management LLC purchased a new position in shares of BJs Wholesale Club in the second quarter worth about $144,291,000. JPMorgan Chase & Co. lifted its holdings in shares of BJs Wholesale Club by 5.7 …

Stock Analysts’ New Coverage for December, 3rd (AGYS, BAND, BBIO, BYDDF, BYSI, CDAY, CNTG, CURLF, FB, FICO) | 12/3/2019

Stock Analysts’ new coverage for Tuesday, December 3rd: Craig Hallum assumed coverage on shares of Agilysys (NASDAQ:AGYS) . The firm issued a buy rating on the stock. Get Agilysys Inc alerts: Needham & Company LLC initiated coverage on shares of Bandwidth (NASDAQ:BAND) . The firm issued a buy rating and a $65.00 target price on the stock. UBS Group AG initiated coverage on shares of BridgeBio Pharma (NASDAQ:BBIO) . The firm …

Guardant Health (NASDAQ:GH) Downgraded by ValuEngine to “Hold” | Daily Political | 12/3/2019

… the company in a research note on Tuesday, November 12th. Cowen set a $110.00 target price on Guardant Health and gave the stock a “buy” rating in a research note on Wednesday, August 7th. William Blair reaffirmed an “outperform” rating on shares of Guardant Health in a research note on Friday, November 8th. Canaccord Genuity reaffirmed a “buy” rating and issued a $125.00 target price on shares of Guardant Health …

Guardant Health (NASDAQ:GH) Downgraded by ValuEngine to “Hold” - Ticker Report | 12/3/2019

… for the company in a report on Tuesday, November 12th. Canaccord Genuity restated a “buy” rating and issued a $125.00 price objective on shares of Guardant Health in a report on Friday, November 8th. William Blair restated an “outperform” rating on shares of Guardant Health in a report on Friday, November 8th. Cowen set a $110.00 price objective on Guardant Health and gave the company a “buy” rating in a …

Audentes Therapeutics (BOLD) Receives a Hold from William Blair | 12/3/2019

Audentes Therapeutics (BOLD) Receives a Hold from William Blair Christine Brown - December 3, 2019, 5:31 AM EDT SHARE ON: In a report released today, Raju Prasad from William Blair maintained a Hold rating on Audentes Therapeutics ( BOLD ). $28.61. Prasad is a 5-star analyst with an average return of 21.4% and a 61.2% success rate. Prasad covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Alexion Pharmaceuticals …

Abbott Laboratories (NYSE:ABT) Receives Consensus Recommendation of “Buy” from Analysts | 12/3/2019

… on Monday, October 14th. Credit Suisse Group upped their target price on Abbott Laboratories from $95.00 to $98.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Finally, William Blair restated an “underperform” rating on shares of Abbott Laboratories in a research note on Thursday, October 17th. Get Abbott Laboratories alerts: In other news, SVP Randel William Woodgrift sold 21,000 shares of the company’s …

NeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Rating of “Buy” from Brokerages | 12/3/2019

… on Tuesday, November 5th. Needham & Company LLC increased their price objective on shares of NeoGenomics from $27.00 to $29.00 and gave the company a “buy” rating in a research report on Wednesday, October 30th. William Blair reiterated an “outperform” rating on shares of NeoGenomics in a research note on Tuesday, October 29th. Finally, ValuEngine upgraded NeoGenomics from a “hold” rating to a “buy” rating in a research note on Friday …

Fitbit Inc (NYSE:FIT) Receives $6.61 Average PT from Brokerages - TheOlympiaReport | 12/3/2019

… year is $6.61. A number of research analysts have commented on the stock. ValuEngine downgraded shares of Fitbit from a “buy” rating to a “hold” rating in a research report on Tuesday, November 19th. William Blair reaffirmed a “hold” rating on shares of Fitbit in a research report on Thursday, August 29th. Craig Hallum downgraded shares of Fitbit from a “buy” rating to a “hold” rating and set a $7.30 …

DIGITAL RLTY TR/SH (NYSE:DLR) Receives Average Recommendation of “Buy” from Brokerages | 12/3/2019

… brokerages have recently commented on DLR. Barclays set a $162.00 price objective on shares of DIGITAL RLTY TR/SH and gave the company a “buy” rating in a research report on Friday, October 11th. William Blair upgraded shares of DIGITAL RLTY TR/SH from a “market perform” rating to an “outperform” rating in a research report on Wednesday, October 30th. KeyCorp lifted their price objective on shares of DIGITAL RLTY …

Ovid Therapeutics (NASDAQ:OVID) Stock Price Down 5.2% | Daily Political | 12/3/2019

… reports on OVID. Royal Bank of Canada initiated coverage on shares of Ovid Therapeutics in a report on Wednesday, September 4th. They set an “outperform” rating and a $12.00 target price on the stock. William Blair restated a “buy” rating on shares of Ovid Therapeutics in a research note on Friday, November 22nd. Citigroup boosted their price target on shares of Ovid Therapeutics from $8.00 to $10.00 and gave the …

PrismHR Announces Investment from Stone Point Capital to Fuel Growth | PR Newswire | 12/2/2019

HOPKINTON, Mass. , Dec. 2, PrismHR, the leading HR technology platform powering payroll, benefits and HR for small and medium-sized businesses across the U.S., today announced that funds managed by Stone Point Capital LLC have taken a majority stake in the company. Stone Point , a leading private equity firm focused on investing in the financial services industry, joins existing investor Summit Partners as the company continues its quest to fuel …

Medical Research

Andra AP fonden Boosts Stock Position in EXACT Sciences Co. (NASDAQ:EXAS) - American Banking News | 12/4/2019

… according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 18,000 shares of the medical research company’s stock after acquiring an additional 2,700 shares during the quarter. Andra AP … EXACT Sciences in a research note on Thursday, October 31st. William Blair reissued a “buy” rating on shares of EXACT Sciences in a report on Tuesday, September 10th. Finally, Leerink Swann decreased their price target …

Princeton Global Asset Management LLC Purchases 690 Shares of Amgen, Inc. (NASDAQ:AMGN) | 12/4/2019

… to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,798 shares of the medical research company’s stock after purchasing an additional 690 shares during the quarter. Princeton Global … neutral” rating and a $215.00 target price for the company. William Blair reiterated a “hold” rating on shares of Amgen in a report on Friday, August 30th. Cantor Fitzgerald upgraded Amgen from a “neutral” rating …

CRISPR

Crispr Therapeutics (NASDAQ:CRSP) Reaches New 52-Week High at $74.00 - Dakota Financial News | 12/4/2019

Crispr Therapeutics AG (NASDAQ:CRSP) shares reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $74.00 and last traded at $72.61, with a volume of 447290 … Crispr Therapeutics in a research note on Tuesday, November 19th. William Blair raised shares of Crispr Therapeutics from a “market perform” rating to an “outperform” rating in a report on Tuesday, November 19th. Finally, TheStreet …

BidaskClub Upgrades Crispr Therapeutics (NASDAQ:CRSP) to Strong-Buy - Ticker Report | 12/2/2019

Crispr Therapeutics (NASDAQ:CRSP) was upgraded by equities research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a report released on Saturday, BidAskClub reports. A number of other brokerages also recently issued reports on CRSP. TheStreet upgraded shares of Crispr Therapeutics from a “d” rating to a “c” note on Monday, October 28th. William Blair upgraded shares of Crispr Therapeutics from a “market perform” rating …

Molecular Diagnostics

Andra AP fonden Boosts Stock Position in EXACT Sciences Co. (NASDAQ:EXAS) - American Banking News | 12/4/2019

… rating and set a $135.00 target price on shares of EXACT Sciences in a research note on Thursday, October 31st. William Blair reissued a “buy” rating on shares of EXACT Sciences in a report on … by insiders. EXACT Sciences Company Profile Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a …

Pictet Asset Management Ltd. Boosts Stock Position in Guardant Health Inc (NASDAQ:GH) | 12/3/2019

… Tuesday, November 12th. JPMorgan Chase & Co. boosted their price objective on Guardant Health from $90.00 to $135.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Finally, William Blair reiterated an “outperform” rating on shares of Guardant Health in a research note on Friday, November 8th. One equities research analyst has rated the stock with a hold rating, five have assigned a buy rating …

Gene Therapy

Audentes Therapeutics (BOLD) Receives a Hold from William Blair | 12/3/2019

Audentes Therapeutics (BOLD) Receives a Hold from William Blair Christine Brown - December 3, 2019, 5:31 AM EDT SHARE ON: In a report released today, Raju Prasad from William Blair maintained a Hold rating on Audentes … a biotechnology company, which engages on development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. Its products include AT001 for the treatment of X-Linked …

Insider Selling: Sarepta Therapeutics Inc (NASDAQ:SRPT) EVP Sells 25,000 Shares of Stock - Ticker Report | 11/28/2019

… 196.00 to $170.00 and set a “buy” rating on the stock in a research report on Wednesday, August 21st. Finally, William Blair reissued a “buy” rating on shares of Sarepta Therapeutics in a research report … focuses on the discovery and development of RNA-based therapeutics, gene therapy, and other genetic medicine approaches for the treatment of rare diseases. The company offers EXONDYS 51, a disease-modifying therapy for duchenne muscular …

Nurse Staffing

$575.50 Million in Sales Expected for AMN Healthcare Services, Inc. (NYSE:AMN) This Quarter - WKRB News | 12/3/2019

… target on AMN Healthcare Services and gave the company a “buy” rating in a research note on Wednesday, August 7th. William Blair restated an “outperform” rating on shares of AMN Healthcare Services in a report … Tenens Solutions, and Other Workforce Solutions. The company offers travel nurse staffing under the American Mobile, Onward Healthcare, Nurses Rx, and O’Grady-Peyton brands; nurse staffing and labor disruption services, a shorter-term staffing solution …

Barclays PLC Buys 6,975 Shares of AMN Healthcare Services, Inc. (NYSE:AMN) | 12/2/2019

… of AMN Healthcare Services and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Finally, William Blair reissued an “outperform” rating on shares of AMN Healthcare Services in a research … Tenens Solutions, and Other Workforce Solutions. The company offers travel nurse staffing under the American Mobile, Onward Healthcare, Nurses Rx, and O’Grady-Peyton brands; nurse staffing and labor disruption services, a shorter-term staffing solution …

Clinical Analytics

Health Catalyst (NASDAQ:HCAT) Stock Price Up 6% - Dakota Financial News | 12/1/2019

… shares. The stock had previously closed at $37.48. HCAT has been the topic of a number of recent research reports. William Blair initiated coverage on Health Catalyst in a report on Monday, August 19th. They … financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services. See Also: Derivative Receive News & Ratings for Health Catalyst Daily - Enter your email address below …

Health Catalyst (NASDAQ:HCAT) Shares Up 6% - TheOlympiaReport | 11/30/2019

… in a report on Monday, August 19th. They issued an “outperform” rating and a $55.00 target price on the stock. William Blair started coverage on shares of Health Catalyst in a report on Monday, August … financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services. Further Reading: What is net income …

Advanced Analytics

Guardant Health (GH) – Investment Analysts’ Weekly Ratings Changes | 11/29/2019

… is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company’s Guardant Health Oncology Platform is designed for clinical development, regulatory and … Guardant Health had its “outperform” rating reaffirmed by analysts at William Blair. 11/8/2019 – Guardant Health had its “buy” rating reaffirmed by analysts at Canaccord Genuity. They now have a $125.00 price target on the stock …

Guardant Health (GH) – Investment Analysts’ Weekly Ratings Changes - Dakota Financial News | 11/29/2019

… is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company’s Guardant Health Oncology Platform is designed for clinical development, regulatory and … Guardant Health had its “outperform” rating reaffirmed by analysts at William Blair. 11/8/2019 – Guardant Health had its “buy” rating reaffirmed by analysts at Canaccord Genuity. They now have a $125.00 price target on the stock …

Hospital Readmissions

Zebra Capital Management LLC Trims Position in Amedisys Inc (NASDAQ:AMED) - TheOlympiaReport | 11/29/2019

… owns 1,349,405 shares of the health services provider’s stock worth $163,831,000 after buying an additional 999,892 shares during the period. William Blair Investment Management LLC raised its position in shares of Amedisys by 937.5% in … chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, social workers, and aides for its patients to complete their important personal tasks …

SG Americas Securities LLC Has $392,000 Stake in Amedisys Inc (NASDAQ:AMED) | 11/26/2019

… 1,349,405 shares of the health services provider’s stock worth $163,831,000 after acquiring an additional 999,892 shares in the last quarter. William Blair Investment Management LLC raised its stake in Amedisys by 937.5% during the second … chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, social workers, and aides for its patients to complete their important personal tasks.See …

Nurse Call Systems

Research Analysts Issue Forecasts for Vocera Communications Inc’s FY2019 Earnings (NYSE:VCRA) | 11/25/2019

Vocera Communications Inc (NYSE:VCRA) – Stock analysts at William Blair upped their FY2019 EPS estimates for Vocera Communications in a research report issued to clients and investors on Thursday, November 21st. William Blair analyst R … solution integrated with other clinical systems, including electronic health records, nurse call systems, and patient monitoring, as well as to provide critical data, alerts, alarms, and clinical context that enable workflow. Receive News & Ratings for …

Vocera Communications (NYSE:VCRA) Research Coverage Started at Royal Bank of Canada | 11/24/2019

… research report on Friday, August 23rd. They issued a buy rating and a $30.00 price objective on the stock. Finally, William Blair reaffirmed a buy rating on shares of Vocera Communications in a research report … solution integrated with other clinical systems, including electronic health records, nurse call systems, and patient monitoring, as well as to provide critical data, alerts, alarms, and clinical context that enable workflow …

Patient Monitoring

Research Analysts Issue Forecasts for Vocera Communications Inc’s FY2019 Earnings (NYSE:VCRA) | 11/25/2019

Vocera Communications Inc (NYSE:VCRA) – Stock analysts at William Blair upped their FY2019 EPS estimates for Vocera Communications in a research report issued to clients and investors on Thursday, November 21st. William Blair analyst R … clinical systems, including electronic health records, nurse call systems, and patient monitoring, as well as to provide critical data, alerts, alarms, and clinical context that enable workflow. Receive News & Ratings for Vocera Communications analysts’ ratings …

Vocera Communications (NYSE:VCRA) Research Coverage Started at Royal Bank of Canada | 11/24/2019

… research report on Friday, August 23rd. They issued a buy rating and a $30.00 price objective on the stock. Finally, William Blair reaffirmed a buy rating on shares of Vocera Communications in a research report … clinical systems, including electronic health records, nurse call systems, and patient monitoring, as well as to provide critical data, alerts, alarms, and clinical context that enable workflow …

Abbott Laboratories

Abbott Laboratories (NYSE:ABT) Shares Sold by Man Group plc | Daily Political | 12/4/2019

Man Group plc cut its stake in Abbott Laboratories (NYSE:ABT) by 31.0% during the third its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 145,013 shares of the … a “buy” rating to a “hold” Wednesday, October 2nd. Finally, William Blair reaffirmed an “underperform” rating on shares of Abbott Laboratories in a report on Thursday, October 17th. Two analysts have rated the stock with …

Abbott Laboratories (NYSE:ABT) Receives Consensus Recommendation of “Buy” from Analysts | 12/3/2019

Shares of Abbott Laboratories (NYSE:ABT) have earned a consensus recommendation of “Buy” from the eighteen ratings firms that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with … rating in a research note on Thursday, October 17th. Finally, William Blair restated an “underperform” rating on shares of Abbott Laboratories in a research note on Thursday, October 17th. Get Abbott Laboratories alerts: In other …

Henry Schein

Henry Schein (NASDAQ:HSIC) Price Target Raised to $71.00 at Bank of America - TheOlympiaReport | 12/4/2019

Henry Schein (NASDAQ:HSIC) had its price target boosted by Bank of America from $69.00 to $71.00 in a research report sent to investors on Tuesday morning, BenzingaRatingsTable reports. They currently have a neutral rating … Schein in a research report on Friday, November 1st. Finally, William Blair downgraded shares of Henry Schein from an outperform rating to a market perform rating in a report on Wednesday, August 7th. Four research …

🌎 NIO Initiated, Fiserv Initiated, Wingstop Upgraded and more… | 12/3/2019

… neutral” rating on the stock. current price of $4.72. Read More . Beyondspring ( NASDAQ:BYSI ) is now covered by analysts at William Blair. They set an “outperform” rating on the stock. current price of $12.69. Read … 15.5% upside from the current price of $95.25. Read More . Henry Schein ( NASDAQ:HSIC ) had its price target raised by analysts at Bank of America Corp from $69.00 to $71.00. They now have a “neutral …

Amgen

Princeton Global Asset Management LLC Purchases 690 Shares of Amgen, Inc. (NASDAQ:AMGN) | 12/4/2019

Princeton Global Asset Management LLC grew its position in Amgen, Inc. (NASDAQ:AMGN) by 22.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund … neutral” rating and a $215.00 target price for the company. William Blair reiterated a “hold” rating on shares of Amgen in a report on Friday, August 30th. Cantor Fitzgerald upgraded Amgen from a “neutral” rating …

Amgen (NASDAQ:AMGN) Sets New 1-Year High at $236.00 | Daily Political | 12/4/2019

Amgen, Inc. (NASDAQ:AMGN)’s share price hit a new 52-week high on Monday . The stock traded as high as $236.00 and last traded at $233.96, with a volume of 6987 shares traded. The stock $234.72.AMGN has been the subject of several recent analyst reports. Evercore ISI reissued a “hold” rating on shares of Amgen in a research note on Sunday, August 11th. William Blair reaffirmed a “hold …

Fitbit

Fitbit Inc (NYSE:FIT) Expected to Announce Earnings of $0.03 Per Share | 12/4/2019

Wall Street analysts expect Fitbit Inc (NYSE:FIT) to announce earnings of $0.03 per share for the current quarter, according to Zacks . Four analysts have issued estimates for Fitbit’s earnings. The lowest EPS estimate is … on the stock. in a report on Friday, November 1st. William Blair reissued a “hold” rating on shares of Fitbit in a research report on Thursday, August 29th. Finally, Craig Hallum lowered shares of Fitbit

Zacks: Brokerages Anticipate Fitbit Inc (NYSE:FIT) Will Post Earnings of $0.03 Per Share | Daily Political | 12/4/2019

Analysts forecast that Fitbit Inc (NYSE:FIT) will announce earnings per share of $0.03 for the current fiscal quarter, according to Zacks Investment Research . Four analysts have issued estimates for Fitbit’s earnings, with the lowest … shares of Fitbit from a “buy” Tuesday, November 19th. Finally, William Blair reissued a “hold” rating on shares of Fitbit Thursday, August 29th. Eight hold rating and one has given a buy rating to the …

Huron Consulting Group

Huron Consulting Group (NASDAQ:HURN) Sets New 12-Month High at $68.71 - Stock Observer | 12/4/2019

Huron Consulting Group (NASDAQ:HURN) shares hit a new 52-week high during trading on Wednesday . The stock traded as high as $68.71 and last traded at $68.64, with a volume of 4420 shares traded … rating in a research report on Wednesday, October 2nd. Finally, William Blair reiterated an “outperform” rating on shares of Huron Consulting Group in a report on Thursday, September 12th. Two analysts have rated the stock …

Huron Consulting Group (NASDAQ:HURN) Short Interest Update - TheOlympiaReport | 11/29/2019

Huron Consulting Group (NASDAQ:HURN) was the recipient of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 232,300 shares, an increase of 39.4 … rating in a research note on Wednesday, July 31st. Finally, William Blair reissued an “outperform” rating on shares of Huron Consulting Group in a research note on Thursday, September 12th. Two investment analysts have rated …

Huron Consulting

Huron Consulting Group (NASDAQ:HURN) Sets New 12-Month High at $68.71 - Stock Observer | 12/4/2019

Huron Consulting Group (NASDAQ:HURN) shares hit a new 52-week high during trading on Wednesday . The stock traded as high as $68.71 and last traded at $68.64, with a volume of 4420 shares traded … rating in a research report on Wednesday, October 2nd. Finally, William Blair reiterated an “outperform” rating on shares of Huron Consulting Group in a report on Thursday, September 12th. Two analysts have rated the stock …

Huron Consulting Group (NASDAQ:HURN) Short Interest Update - TheOlympiaReport | 11/29/2019

Huron Consulting Group (NASDAQ:HURN) was the recipient of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 232,300 shares, an increase of 39.4 … rating in a research note on Wednesday, July 31st. Finally, William Blair reissued an “outperform” rating on shares of Huron Consulting Group in a research note on Thursday, September 12th. Two investment analysts have rated …

Verisk Analytics

NexPhase Capital Announces Sale of FAST to Verisk | PR Newswire | 12/4/2019

… Architecture & Simplified Technology, LLC (“FAST” or the “Company”), a leading software company for the life insurance and annuity industry, to Verisk Analytics, Inc. (“Verisk”). Founded in 2010, FAST is a leader among technology companies, supporting … OmniSYS, Insurance Technologies, Inside Real Estate, SwipeClock, and Mxi Technologies. William Blair acted as exclusive financial advisor to NexPhase and the Company on this transaction, and Lowenstein Sandler LLP acted as legal advisor. About NexPhase …

AMN Healthcare Services

$575.50 Million in Sales Expected for AMN Healthcare Services, Inc. (NYSE:AMN) This Quarter - WKRB News | 12/3/2019

Wall Street analysts expect AMN Healthcare Services, Inc. (NYSE:AMN) to post $575.50 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have provided estimates for AMN Healthcare Services’ earnings, with … buy” rating in a research note on Wednesday, August 7th. William Blair restated an “outperform” rating on shares of AMN Healthcare Services in a report on Friday, September 20th. Zacks Investment Research cut AMN Healthcare …

Barclays PLC Buys 6,975 Shares of AMN Healthcare Services, Inc. (NYSE:AMN) | 12/2/2019

Barclays PLC grew its stake in shares of AMN Healthcare Services, Inc. (NYSE:AMN) by 12.6% during the third the company in its most recent disclosure with the SEC. The fund owned 62,476 shares of … rating in a research note on Wednesday, August 7th. Finally, William Blair reissued an “outperform” rating on shares of AMN Healthcare Services in a research note on Friday, September 20th. One research analyst has rated …

AMN Healthcare

$575.50 Million in Sales Expected for AMN Healthcare Services, Inc. (NYSE:AMN) This Quarter - WKRB News | 12/3/2019

Wall Street analysts expect AMN Healthcare Services, Inc. (NYSE:AMN) to post $575.50 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have provided estimates for AMN Healthcare Services’ earnings, with … buy” rating in a research note on Wednesday, August 7th. William Blair restated an “outperform” rating on shares of AMN Healthcare Services in a report on Friday, September 20th. Zacks Investment Research cut AMN Healthcare

Barclays PLC Buys 6,975 Shares of AMN Healthcare Services, Inc. (NYSE:AMN) | 12/2/2019

Barclays PLC grew its stake in shares of AMN Healthcare Services, Inc. (NYSE:AMN) by 12.6% during the third the company in its most recent disclosure with the SEC. The fund owned 62,476 shares of … rating in a research note on Wednesday, August 7th. Finally, William Blair reissued an “outperform” rating on shares of AMN Healthcare Services in a research note on Friday, September 20th. One research analyst has rated …

Guardant Health

Pictet Asset Management Ltd. Boosts Stock Position in Guardant Health Inc (NASDAQ:GH) | 12/3/2019

Pictet Asset Management Ltd. boosted its holdings in Guardant Health Inc (NASDAQ:GH) by 172.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The … rating in a research note on Wednesday, August 7th. Finally, William Blair reiterated an “outperform” rating on shares of Guardant Health in a research note on Friday, November 8th. One equities research analyst has rated …

Guardant Health (NASDAQ:GH) Downgraded by ValuEngine to “Hold” | Daily Political | 12/3/2019

Guardant Health (NASDAQ:GH) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a report issued on Tuesday, ValuEngine reports.Several other research analysts also recently commented on GH … buy” rating in a research note on Wednesday, August 7th. William Blair reaffirmed an “outperform” rating on shares of Guardant Health in a research note on Friday, November 8th. Canaccord Genuity reaffirmed a “buy” rating …

Morgan Stanley

General Electric (NYSE:GE) Given a $11.00 Price Target by Credit Suisse Group Analysts - TheOlympiaReport | 12/4/2019

Morgan Stanley initiated coverage on shares of General Electric in a research report on Thursday, September 5th. They issued an equal weight rating and a $10.00 price objective for the company. William Blair reaffirmed a buy rating on shares of General Electric in a research report on Friday, August 16th. Finally, JPMorgan Chase & Co. set a $5.00 price objective on General Electric and gave the stock an underweight rating in …

General Electric’s (GE) “Buy” Rating Reiterated at William Blair | 12/4/2019

General Electric’s (GE) “Buy” Rating Reiterated at William Blair Posted by Bonnie Powley on Dec 4th, 2019 Tweet General Electric (NYSE:GE) ‘s stock had its “buy” rating reaffirmed by analysts at William Blair in a research note issued on Tuesday, TipRanks reports. Several other research firms have also issued reports on GE. Morgan Stanley initiated coverage on General Electric in a research note on Thursday, September 5th. They set …

Goldman Sachs

Princeton Global Asset Management LLC Purchases 690 Shares of Amgen, Inc. (NASDAQ:AMGN) | 12/4/2019

Goldman Sachs Group set a $243.00 target price on Amgen and gave the stock a “buy” rating in a report on Monday, September 30th. Bank of America assumed coverage on Amgen in a research note on Wednesday, October 16th. They issued a “neutral” rating and a $215.00 target price for the company. William Blair reiterated a “hold” rating on shares of Amgen in a report on Friday, August 30th. Cantor …

Amgen (NASDAQ:AMGN) Sets New 1-Year High at $236.00 | Daily Political | 12/4/2019

William Blair reaffirmed a “hold” rating on shares of Amgen in a research note on Friday, August 30th. Oppenheimer set a $240.00 price target on shares of Amgen and gave the company a “buy” rating in a research note on Monday, September 9th. BidaskClub upgraded shares of Amgen from a “buy” rating to a “strong-buy” rating in a report on Wednesday, November 13th. Finally, Goldman Sachs Group set a …

Citigroup

Golub Group LLC Sells 29,784 Shares of General Electric (NYSE:GE) | 12/4/2019

… rating and issued a $12.00 price objective on shares of General Electric in a research note on Friday, October 4th. Citigroup set a $14.00 price target on shares of General Electric and gave the company … rating in a research note on Friday, November 1st. Finally, William Blair reiterated a “buy” rating on shares of General Electric in a report on Friday, August 16th. Three analysts have rated the stock with …

Stock Analysts’ Updated EPS Estimates for December, 4th (ALIM, APDN, AVNW, BOLD, CDTX, CHGG, CRM, DENN, DRI, ENB) | 12/4/2019

… currently has a $190.00 target price on the stock. salesforce.com (NYSE:CRM) had its outperform rating reiterated by analysts at William Blair. salesforce.com (NYSE:CRM) had its buy rating reiterated by analysts at Cowen Inc … NYSE:HLF) had its buy rating reaffirmed by analysts at Citigroup Inc. Citigroup Inc currently has a $55.00 target price on the stock. Healthequity (NASDAQ:HQY) had its buy rating reissued by analysts at Cantor …

SunTrust Bank

Huron Consulting Group (NASDAQ:HURN) Sets New 12-Month High at $68.71 - Stock Observer | 12/4/2019

… shares traded. The stock had previously closed at $66.76. HURN has been the subject of a number of analyst reports. SunTrust Banks raised their target price on shares of Huron Consulting Group to $74.00 and … rating in a research report on Wednesday, October 2nd. Finally, William Blair reiterated an “outperform” rating on shares of Huron Consulting Group in a report on Thursday, September 12th. Two analysts have rated the stock …

🌎 NIO Initiated, Fiserv Initiated, Wingstop Upgraded and more… | 12/3/2019

… neutral” rating on the stock. current price of $4.72. Read More . Beyondspring ( NASDAQ:BYSI ) is now covered by analysts at William Blair. They set an “outperform” rating on the stock. current price of $12.69. Read … NYSE:CHCT ) had its price target raised by analysts at SunTrust Banks, Inc. to $50.00. They now have a “positive” rating on the stock. 5.7% upside from the current price of $47.30. Read More . Cloudera …

Maxim Group

ABM Industries, Inc. (NYSE:ABM) Expected to Announce Quarterly Sales of $1.66 Billion | 12/4/2019

William Blair assumed coverage on shares of ABM Industries in a report on Thursday, August 15th. They issued a “market perform” rating on the stock. Finally, Maxim Group set a $50.00 price objective on shares of ABM Industries and gave the company a “buy” rating in a research report on Tuesday, September 3rd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating …

ABM Industries, Inc. (NYSE:ABM) Shares Sold by Barclays PLC - American Banking News | 12/4/2019

William Blair started coverage on shares of ABM Industries in a research report on Thursday, August 15th. They issued a “market perform” rating for the company. Maxim Group set a $50.00 target price on shares of ABM Industries and gave the company a “buy” rating in a research note on Tuesday, September 3rd. ValuEngine lowered ABM Industries from a “hold” rating to a “sell” rating in a report on Friday …

Jefferies Financial Group

Stock Analysts’ New Coverage for December, 3rd (AGYS, BAND, BBIO, BYDDF, BYSI, CDAY, CNTG, CURLF, FB, FICO) | 12/3/2019

… began coverage on shares of BYD/Shs H Vtg 1.00 (OTCMKTS:BYDDF) . They issued a neutral rating on the stock. William Blair started coverage on shares of Beyondspring (NASDAQ:BYSI) . The firm issued an outperform … overweight rating and a $230.00 price target on the stock. Jefferies Financial Group Inc initiated coverage on shares of Fair Isaac (NYSE:FICO) . They issued a hold rating and a $370.00 target price on the …

🌎 NIO Initiated, Fiserv Initiated, Wingstop Upgraded and more… | 12/3/2019

… from $30.00. 2.1% upside from the current price of $58.76. Read More . Danaos ( NYSE:DAC ) was upgraded by analysts at Jefferies Financial Group Inc from a “hold” rating to a “buy” rating. They now have … More . Beyondspring ( NASDAQ:BYSI ) is now covered by analysts at William Blair. They set an “outperform” rating on the stock. current price of $12.69. Read More . Ceridian HCM ( NYSE:CDAY ) is now covered by analysts …

JMP Securities

Stock Analysts’ New Coverage for December, 3rd (AGYS, BAND, BBIO, BYDDF, BYSI, CDAY, CNTG, CURLF, FB, FICO) | 12/3/2019

… began coverage on shares of BYD/Shs H Vtg 1.00 (OTCMKTS:BYDDF) . They issued a neutral rating on the stock. William Blair started coverage on shares of Beyondspring (NASDAQ:BYSI) . The firm issued an outperform … buy rating and a $20.00 target price on the stock. JMP Securities began coverage on shares of TELA Bio (NASDAQ:TELA) . JMP Securities issued an outperform rating and a $22.00 price target on the stock …

🌎 NIO Initiated, Fiserv Initiated, Wingstop Upgraded and more… | 12/3/2019

… neutral” rating on the stock. current price of $4.72. Read More . Beyondspring ( NASDAQ:BYSI ) is now covered by analysts at William Blair. They set an “outperform” rating on the stock. current price of $12.69. Read … TELA Bio ( NASDAQ:TELA ) is now covered by analysts at JMP Securities. They set an “outperform” rating and a $22.00 price target on the stock. 76.0% upside from the current price of $12.50. Read More …

Merrill Lynch

Sponsors Announced for the 2020 ICR Conference | Malvern Daily Record | 12/2/2019

… Merrill Lynch; Barclays; BMO; B. Riley; Citi; Cowen; Credit Suisse; Deutsche Bank; Goldman, Sachs & Co; Guggenheim Partners; Jefferies; J.P. Morgan; KeyBanc Capital Markets; Morgan Stanley; Piper Jaffray; Raymond James; RBC Capital Markets; RSM; Stephens; Stifel; SunTrust Robinson Humphrey; Telsey Advisory Group; Wells Fargo; William Blair; Latham & Watkins; Duff & Phelps; The Sage Group; and Vinson & Elkins LLP. The event is by invitation only. To request an invitation, please visit http://www.icrconference.com …

Equifax Inc (EFX) Q3 2019 Earnings Call Transcript | The Motley Fool | 11/12/2019

… Mihalos – Cowen and Company – Analyst It does. Operator We’ll take our next question from Gary Bisbee with Bank of America Merrill Lynch. Please go ahead. Gary Bisbee – Bank of America Merrill Lynch – Analyst Hi, guys … guys. Appreciate it. Operator Moving next to Andrew Nicholas with William Blair. Please go ahead. Andrew Nicholas – William Blair & Company – Analyst Hi, good morning. I believe you mentioned a comment about the press around the …

RBC Capital Markets

Sponsors Announced for the 2020 ICR Conference | Malvern Daily Record | 12/2/2019

… RBC Capital Markets; RSM; Stephens; Stifel; SunTrust Robinson Humphrey; Telsey Advisory Group; Wells Fargo; William Blair; Latham & Watkins; Duff & Phelps; The Sage Group; and Vinson & Elkins LLP. The event is by invitation only. To request an invitation, please visit http://www.icrconference.com or email [email protected] . About The ICR Conference The ICR Conference is a unique platform where public and private company management teams, institutional investors, sell-side research analysts, investment …

VMware Inc (VMW) Q3 2020 Earnings Call Transcript | The Motley Fool | 11/27/2019

… Wells Fargo – Analyst Thanks guys. Paul Ziots – Vice President, Investor Relations Next question, please. Next we have Matt Hedberg with RBC Capital Markets. Matt Hedberg – RBC Capital Markets – Analyst Hey guys. Thanks for taking my … Investor Relations Next question please. Next is Jason Ader with William Blair. Jason Ader – William Blair – Analyst Hi guys. If I could just play devil’s advocate on Project Pacific, why would I want to integrate …

Summit Partners

PrismHR Announces Investment from Stone Point Capital to Fuel Growth | Markets Insider | Business Insider | 12/2/2019

… the company. Stone Point , a leading private equity firm focused on investing in the financial services industry, joins existing investor Summit Partners as the company continues its quest to fuel the growth of America’s small … platform, and we are looking forward to continuing our partnership.” William Blair served as investment advisors and Kirkland & Ellis served as legal advisors for both PrismHR and Summit Partners in the transaction. Kramer Levin Naftalis …

LHC Group

Stifel Financial Corp Boosts Position in LHC Group, Inc. (NASDAQ:LHCG) - WKRB News | 12/3/2019

Stifel Financial Corp lifted its stake in shares of LHC Group, Inc. (NASDAQ:LHCG) by 64.4% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The … overweight” rating and a $132.00 price objective on the stock. William Blair restated an “outperform” rating on shares of LHC Group in a report on Thursday, November 7th. UBS Group boosted their price objective on …

LHC Group, Inc. (NASDAQ:LHCG) Shares Acquired by Voloridge Investment Management LLC | 12/2/2019

Voloridge Investment Management LLC increased its position in shares of LHC Group, Inc. (NASDAQ:LHCG) by 18.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange … rating and a $145.00 price objective for the company. Finally, William Blair restated an “outperform” rating on shares of LHC Group in a research report on Thursday, November 7th. Four equities research analysts have rated …

Acadia Healthcare

William Blair Analysts Lower Earnings Estimates for Acadia Healthcare Company Inc (NASDAQ:ACHC) - Ticker Report | 11/9/2019

Acadia Healthcare Company Inc (NASDAQ:ACHC) – Equities research analysts at William Blair lowered their FY2019 earnings per share (EPS) estimates for shares of Acadia Healthcare in a report released on Tuesday, November 5th. William Blair analyst R. Daniels now expects that the company will post earnings of $2.02 per share for the year, down from their prior forecast of $2.22. William Blair also issued estimates for Acadia Healthcare’s Q4 2019 …

Equities Analysts Set Expectations for Acadia Healthcare Company Inc’s Q2 2020 Earnings (NASDAQ:ACHC) | 8/26/2019

Equities Analysts Set Expectations for Acadia Healthcare Company Inc’s Q2 2020 Earnings (NASDAQ:ACHC) Posted by Jonathan Perkins on Aug 25th, 2019 Tweet Acadia Healthcare Company Inc (NASDAQ:ACHC) – Equities researchers at William Blair issued their Q2 2020 earnings per share (EPS) estimates for Acadia Healthcare in a note issued to investors on Tuesday, July 30th, according to Zacks Investment Research . William Blair analyst R. Daniels anticipates that the company …

Cleveland Clinic

DaVita (DVA) Q3 2019 Earnings Call Transcript | The Motley Fool | 11/6/2019

… good start. Two supporting points: first, over 500 phases have joined the alliance; and second, Dr. Leslie Wang from the Cleveland Clinic has agreed to join DaVita to lead the way. Next, a few comments … you, John. The next question comes from Matt Larew with William Blair. Your line is now open. Javier Rodriguez – Chief Executive Officer Hi, Matt. Matt Larew – William Blair – Analyst Hey, good afternoon. Thanks for taking …

Vocera Communications (VCRA) CEO Brent Lang on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 10/25/2019

Vocera Communications, Inc. (NYSE: VCRA 5:00 Sue Dooley - IR Brent Lang - CEO Justin Spencer - CFO Ryan Daniels - William Blair Vikram Kesavabhotla - Guggenheim Securities David Windley - Jefferies Matthew Gillmor - Baird Sean Wieland - Piper Jaffray Gene Mannheimer … strategic wins. First, we won a $1.5 million deal at Cleveland Clinic, London. Opening in 2021 and setting the standard for world class private healthcare, Cleveland Clinic selected our full solution and plans to deploy …

HCA

HCA Healthcare Inc Forecasted to Earn FY2019 Earnings of $10.53 Per Share (NYSE:HCA) | 11/5/2019

HCA Healthcare Inc (NYSE:HCA) – Investment analysts at William Blair upped their FY2019 EPS estimates for HCA Healthcare in a research note issued to investors on Wednesday, October 30th. William Blair analyst M. Larew now expects that the company will post earnings per share of $10.53 for the year, up from their previous estimate of $10.34. William Blair also issued estimates for HCA Healthcare’s Q2 2020 earnings at $2.51 EPS …

🌎 Xerox Downgraded, GrubHub Downgraded, National-Oilwell Varco Upgraded and more… | 10/30/2019

… an “outperform” rating. current price of $17.41. Read More . DIGITAL RLTY TR/SH ( NYSE:DLR ) was upgraded by analysts at William Blair from a “market perform” rating to an “outperform” rating. current price of $126.62 … a “hold” rating. current price of $90.96. Read More . Molina Healthcare ( NYSE:MOH ) was downgraded by analysts at Jefferies Financial Group Inc from a “buy” rating to a “hold” rating. They now have a $120.00 …

HCA Healthcare

HCA Healthcare Inc Forecasted to Earn FY2019 Earnings of $10.53 Per Share (NYSE:HCA) | 11/5/2019

HCA Healthcare Inc (NYSE:HCA) – Investment analysts at William Blair upped their FY2019 EPS estimates for HCA Healthcare in a research note issued to investors on Wednesday, October 30th. William Blair analyst M. Larew now expects that the company will post earnings per share of $10.53 for the year, up from their previous estimate of $10.34. William Blair also issued estimates for HCA Healthcare’s Q2 2020 earnings at $2.51 EPS …

🌎 Xerox Downgraded, GrubHub Downgraded, National-Oilwell Varco Upgraded and more… | 10/30/2019

… an “outperform” rating. current price of $17.41. Read More . DIGITAL RLTY TR/SH ( NYSE:DLR ) was upgraded by analysts at William Blair from a “market perform” rating to an “outperform” rating. current price of $126.62 … 24.3% upside from the current price of $35.40. Read More . HCA Healthcare ( NYSE:HCA ) had its price target raised by analysts at Barclays PLC from $145.00 to $155.00. They now have an “overweight” rating on …

Mayo Clinic

Exact Sciences Corp (EXAS) Q3 2019 Earnings Call Transcript | The Motley Fool | 10/30/2019

… the early accurate detection of colorectal cancer.Real-world evidence is critical to supporting continued Cologuard adoption over time. Working with Mayo Clinic, we recently initiated Voyage, a 150,000-patient prospective observational study of individuals using … first question comes from the line of Brian Weinstein with William Blair. Brian Weinstein – William Blair & Company L.L.C. – Analyst Hey, guys. Thanks for taking the questions. Wanted to start out just on a broad question …

Accelerate Diagnostics Is About To Accelerate To The Downside - $6 Price Target - Accelerate Diagnostics, Inc. (NASDAQ:AXDX) | Seeking Alpha | 9/17/2019

… 75% faster AST results; we believe the actual time difference is less than 40% for a modern lab In its William Blair 39th Annual Growth Stock Conference presentation , AXDX claimed 75% or faster AST testing … on 5/9/18, Mehren stated: In late 2017 two institutions, the Mayo Clinic, Rochester and UCLA, secured IRB approval to conduct a randomized clinical trial investigating the efficacy and associate health economic outcomes of Pheno…. Regardless …

Tenet Healthcare

Tenet Healthcare Corp (NYSE:THC) Expected to Earn Q3 2019 Earnings of $0.35 Per Share | 8/16/2019

Tenet Healthcare Corp (NYSE:THC) – Investment analysts at William Blair increased their Q3 2019 EPS estimates for Tenet Healthcare in a research note issued to investors on Tuesday, August 6th, according to Zacks Investment Research . William Blair analyst M. Larew now expects that the company will post earnings per share of $0.35 for the quarter, up from their previous estimate of $0.17. William Blair also issued estimates for Tenet Healthcare’s …

Brokers Issue Forecasts for Tenet Healthcare Corp’s Q3 2019 Earnings (NYSE:THC) | 8/11/2019

Tenet Healthcare Corp (NYSE:THC) – Stock analysts at William Blair raised their Q3 2019 EPS estimates for Tenet Healthcare in a research report issued on Tuesday, August 6th. William Blair analyst M. Larew now forecasts that the company will post earnings per share of $0.35 for the quarter, up from their previous estimate of $0.17. William Blair also issued estimates for Tenet Healthcare’s Q3 2020 earnings at $0.51 EPS. Get …

UPMC

VC-backed Health Catalyst debuts IPO | PE Hub | 7/25/2019

William Blair are the lead underwriters. Health Catalyst’s pre-IPO backers included OrbiMed, Sequoia Capital, Norwest Venture Partners, Sands Capital Ventures, UPMC Enterprises and Kaiser Permanente Ventures. PRESS RELEASE SALT LAKE CITY , July 24, 2019 /CNW/ — Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the pricing of its initial public offering of 7,000,000 shares of its …

IPO Update: Health Catalyst Proposes IPO Terms - Health Catalyst (Pending:HCAT) | Seeking Alpha | 7/15/2019

… well as 75 health systems facilitating the support of over 75 million patients. Investors in Health Catalyst included Sequoia Capital, UPMC, OrbiMed, Norwest Venture Partners, Kaiser Permanente Ventures, and Sands Capital Ventures. Source: Crunchbase Customer … Listed underwriters of the IPO are Goldman Sachs, J.P. Morgan, William Blair, Piper Jaffray, Evercore ISI, SVB Leerink, and SunTrust Robinson Humphrey. Commentary I previously wrote about Health Catalysts IPO prospects in my analysis, First …

Kaiser Permanente

VC-backed Health Catalyst debuts IPO | PE Hub | 7/25/2019

William Blair are the lead underwriters. Health Catalyst’s pre-IPO backers included OrbiMed, Sequoia Capital, Norwest Venture Partners, Sands Capital Ventures, UPMC Enterprises and Kaiser Permanente Ventures. PRESS RELEASE SALT LAKE CITY , July 24, 2019 /CNW/ — Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the pricing of its initial public offering of 7,000,000 shares of its …

IPO Update: Health Catalyst Proposes IPO Terms - Health Catalyst (Pending:HCAT) | Seeking Alpha | 7/15/2019

… facilitating the support of over 75 million patients. Investors in Health Catalyst included Sequoia Capital, UPMC, OrbiMed, Norwest Venture Partners, Kaiser Permanente Ventures, and Sands Capital Ventures. Source: Crunchbase Customer Acquisition HCAT has a dedicated … Listed underwriters of the IPO are Goldman Sachs, J.P. Morgan, William Blair, Piper Jaffray, Evercore ISI, SVB Leerink, and SunTrust Robinson Humphrey. Commentary I previously wrote about Health Catalysts IPO prospects in my analysis, First …

Ascension

Iris Dorbian wrote a new post, VC-backed Phreesia starts trading on the NYSE, on the site PE Hub | 7/18/2019

William Blair are the lead underwriters. Phreesia’s pre-IPO backers included LLR Partners, HLM Venture Partners, Polaris Partners, Ascension Ventures, Echo Health Venture and Blue Cross Blue Shield Venture Partners. PRESS RELEASE NEW YORK, July 17, 2019 /PRNewswire/ — Phreesia, Inc. (“Phreesia”), a leading patient intake management platform, today announced the pricing of its initial public offering of 9,288,194 shares of common stock at a public offering price of $18.00 per …

Phreesia Prepares For U.S. IPO - Phreesia (Pending:PHR) | Seeking Alpha | 7/12/2019

… Management and Electronic Health Record systems. Investors in Phreesia included HLM Venture Partners, BlueCross BlueShield Venture Partners, Polaris Venture Partners, Ascension Ventures, Vantage Point Venture Partners, Echo Health Ventures, LLR Equity Partners, Sandbox Industries, and … the IPO are J.P. Morgan, Wells Fargo Securities, Allen & Company, William Blair, and Piper Jaffray. Commentary Phreesia is a reasonably fast-growing firm that has just crossed the $100 million annual revenue run rate threshold …

Humana

Tivity Health, Inc. (TVTY) CEO Donato Tramuto on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/13/2019

… President of Healthcare Conference Call Participants Alex Fuhrman - Craig-Hallum David MacDonald - SunTrust Robinson Humphrey David Styblo - Jefferies Nicholas Spiekhout - William Blair & Company Operator Good afternoon, and welcome to the Tivity Health Third Quarter 2019 … In addition to the pilot, that Donato mentioned earlier, the Humana food security pilot plans in 2 markets for January 2020 is on track and commitment from Humana is high. The pilot will leverage the …

Morgan Stanley sees 58% upside in Genmab in premarket analyst action - Genmab A/S (NASDAQ:GMAB) | Seeking Alpha | 8/12/2019

William Blair. OncoSec Medical (NASDAQ: ONCS ) initiated with Buy rating and $9 (327% upside) price target at Alliance Global Partners. Humana (NYSE: HUM ) upgraded to Overweight with a $345 (16% upside) price target at Cantor Fitzgerald. Axovant Gene Therapies (NASDAQ: AXGT ) upgraded to Outperform with a $13 (105% upside) price target at Baird. Zimmer Biomet Holdings (NYSE: ZBH ) upgraded to Buy with a $160 (16% upside) price target at Argus …

Aetna

Exact Sciences Corp (EXAS) Q3 2019 Earnings Call Transcript | The Motley Fool | 10/30/2019

… have lowered their coverage screening age for Cologuard to 45, following the American Cancer Society guidelines update last year, including Aetna, CareFirst and Blue Shield of California. This is encouraging progress and our team is … first question comes from the line of Brian Weinstein with William Blair. Brian Weinstein – William Blair & Company L.L.C. – Analyst Hey, guys. Thanks for taking the questions. Wanted to start out just on a broad question …

Quest Diagnostics’ (DGX) CEO Steve Rusckowski on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 10/22/2019

… Ellich – Craig-Hallum Jack Meehan – Barclays Kevin Caliendo – UBS Brian Tanquilut – Jefferies Derik de Bruin – Bank of America Matt Larew – William Blair Alexa Desai – Morgan Stanley Mark Massaro – Canaccord Genuity Eric Coldwell – Baird Stephen Baxter … in the marketplace, so we continue to work with CVS, Aetna, the MinuteClinic and what we’re doing around their strategy is they are a partner of ours. Operator Our next question comes from Ricky Goldwasser …

Cigna

Exact Sciences Corp (EXAS) Q3 2019 Earnings Call Transcript | The Motley Fool | 10/30/2019

… question. Questions and Answers: Operator Thank you. [Operator Instructions] Your first question comes from the line of Brian Weinstein with William Blair. Brian Weinstein – William Blair & Company L.L.C. – Analyst Hey, guys. Thanks for taking the … quarter.And in September, we had some new coverage wins with Cigna and Anthem. And then, in the start of the fourth quarter, our Pfizer partnership began. So there is a lot of unique tailwind to …

BioDelivery Sciences International, Inc. (BDSI) CEO Herm Cukier on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/9/2019

… Call Participants Oren Livnat - H.C. Wainwright & Company Brandon Folkes - Cantor Fitzgerald Scott Henry - ROTH Capital Esther Hong - Janney Tim Lugo - William Blair Matt Kaplan - Ladenburg Thalmann Operator Good day and welcome to the BioDelivery Sciences … million lives. During our Q1 call, we discussed the recent Cigna commercial formulary wins and I’m excited to report the sales team has done excellent job of executing, following prescriptions within the plan by 31 …

The Health Plan

Quest Diagnostics’ (DGX) CEO Steve Rusckowski on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 10/22/2019

… Ellich – Craig-Hallum Jack Meehan – Barclays Kevin Caliendo – UBS Brian Tanquilut – Jefferies Derik de Bruin – Bank of America Matt Larew – William Blair Alexa Desai – Morgan Stanley Mark Massaro – Canaccord Genuity Eric Coldwell – Baird Stephen Baxter … not all third-party reimbursement where we’re contractually agreed with the health plan and what those rates are in the hospital business and also where we sell directly to physicians and they’re allowed to build …

LHC Group’s (LHCG) CEO Keith Myers on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/11/2019

… Stelly - President & COO Conference Call Participants Brain Tanquilut - Jefferies Joanna Gajuk - Bank of America Kevin Elitch - Craig-Hallum Matt Larew - William Blair Matthew Gillmor - Robert Baird Dana Hambly - Stephens Whit Mayo - UBS Operator Good day … a sense for conversations you’re having relative to opportunity with the health plan, but what are you picking out as targets for success over the next 12 to 18 months? What can you describe as …

Magellan Health

Magellan Health Inc (NASDAQ:MGLN) Shares Sold by William Blair Investment Management LLC | 9/6/2019

William Blair Investment Management LLC lowered its position in shares of Magellan Health Inc (NASDAQ:MGLN) by 9.9% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 175,953 shares of the company’s stock after selling 19,352 shares during the quarter. William Blair Investment Management LLC’s holdings in Magellan Health were worth $13,061,000 as of its most recent filing …

William Blair Investment Management LLC Sells 19,352 Shares of Magellan Health Inc (NASDAQ:MGLN) - WKRB News | 9/6/2019

William Blair Investment Management LLC lessened its holdings in Magellan Health Inc (NASDAQ:MGLN) by 9.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 175,953 shares of the company’s stock after selling 19,352 shares during the quarter. William Blair Investment Management LLC owned 0.72% of Magellan Health worth $13,061,000 as of its most recent filing with the …

Centene Corp

William Blair Investment Management LLC Buys 40,855 Shares of Centene Corp (NYSE:CNC) | 9/4/2019

William Blair Investment Management LLC lifted its stake in Centene Corp (NYSE:CNC) by 14.0% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 332,254 shares of the company’s stock after buying an additional 40,855 shares during the quarter. William Blair Investment Management LLC owned about 0.08% of Centene worth $17,423,000 as of its most recent filing with the Securities & Exchange …

Oppenheimer & Co. Inc. Has $4.14 Million Stock Position in Centene Corp (NYSE:CNC) | 9/4/2019

Oppenheimer & Co. Inc. Has $4.14 Million Stock Position in Centene Corp (NYSE:CNC) Posted by Caroline Horne Sep 4th, 2019 Oppenheimer & Co. Inc. grew its stake in shares of Centene Corp (NYSE:CNC) by 12.1 … after acquiring an additional 402,695 shares in the last quarter. William Blair Investment Management LLC increased its position in shares of Centene by 14.0% during the second quarter. William Blair Investment Management LLC now owns …

MedPartners

AMN Healthcare Services, Inc. (AMN) CEO Susan Salka on Q2 2019 Results - Earnings Call Transcript | Seeking Alpha | 8/7/2019

… and Company Tobey Sommer - SunTrust A.J. Rice - Credit Suisse Mark Marcon - R.W. Baird Bill Sutherland - The Benchmark Company Tim McHugh - William Blair Operator Ladies and gentlemen, thank you for standing by, and welcome to AMN … Within our mid-revenue cycle business, the integration of our MedPartners and Peak brands is progressing very nicely and I’m impressed with their new go-to-market strategy and collaboration with our other businesses. Although …

AMN Healthcare Services’ (AMN) CEO Susan Salka on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/4/2019

… Conference Call Participants A.J. Rice – Crédit Suisse Tobey Sommer – SunTrust Jason Plagman – Jefferies and Company Jeff Silber – BMO Tim McHugh – William Blair Jacob Johnson – Stephens Inc Mitra Ramgopal – Sidoti & Company Mark Marcon – R.W. Baird Bill … year-over-year variance was due to the acquisition of MedPartners partly offset by the physician perm placement reclassification. On a consolidated basis, first quarter adjusted EBITDA of $66 million was down 1% year-over …

UnitedHealthcare

Tivity Health’s (TVTY) CEO Donato Tramuto on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/9/2019

… and Integration Initiatives Conference Call Participants Steve Halper – Cantor Fitzgerald Alex Fuhrman – Craig-Hallum Capital Mohan Naidu – Oppenheimer Nick Spiekhout – William Blair Dave Styblo – Jefferies Nina Deka – Piper Jaffray Operator Good afternoon, and welcome to … decrease in total eligible SilverSneakers lives, including the loss of UnitedHealthcare lives we previously discussed. As you may know, approximately 75% of our eligible lives are under our hybrid contract, whereby we receive payment from …

Laboratory Corporation of America Holdings (LH) CEO David King on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 4/30/2019

… rest of the quarter. We also pleased that LabCorp and all of its specialty-branded laboratories were selected to be UnitedHealthcare preferred laboratory network providers. LabCorp’s selection reflects a long and deep partnership with United … next question comes from the line of Matt Larew with William Blair. Your line is now open. Unidentified Conference Call Participant Hi, good morning guys. This is [indiscernible] on for Matt Larew. Thanks for taking …

Janney Montgomery Scott

Henry Schein (NASDAQ:HSIC) Price Target Raised to $71.00 at Bank of America - TheOlympiaReport | 12/4/2019

… Cleveland Research reaffirmed a hold rating on shares of Henry Schein in a research report on Friday, November 1st. Finally, William Blair downgraded shares of Henry Schein from an outperform rating to a market perform … in Henry Schein in the second quarter worth approximately $40,000. Janney Montgomery Scott LLC grew its holdings in Henry Schein by 89.7% during the 2nd quarter. Janney Montgomery Scott LLC now owns 24,882 shares of …

Point72 Asset Management L.P. Sells 186,973 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - TheOlympiaReport | 12/3/2019

… Commerzbank Aktiengesellschaft FI now owns 5,276 shares of the biotechnology company’s stock valued at $452,000 after buying an additional 586 Janney Montgomery Scott LLC increased its stake in shares of BioMarin Pharmaceutical by 70.0% during … the stock. in a research report on Wednesday, November 6th. William Blair reissued a “buy” rating on shares of BioMarin Pharmaceutical in a research report on Friday, November 15th. JPMorgan Chase & Co. restated a “buy …

Steven Paladino

Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Chevy Chase Trust Holdings Inc. | 12/2/2019

William Blair cut Henry Schein from an “outperform” rating to a “market perform” rating in a report on Wednesday, August 7th. Five equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and five have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $72.17. In related news, CFO Steven …

State Street Corp Sells 70,865 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - Dakota Financial News | 12/2/2019

… sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink . Also, CFO Steven Paladino sold 21,370 shares of Henry Schein stock in a transaction on Thursday, November … company. in a research note on Wednesday, November 6th. Finally, William Blair lowered Henry Schein from an “outperform” rating to a “market perform” rating in a research note on Wednesday, August 7th. Five equities research …

Ed Jones

AxoGen (NASDAQ:AXGN) Rating Increased to Sell at BidaskClub - Modern Readers | 11/27/2019

AxoGen (NASDAQ:AXGN) Rating Increased to Sell at BidaskClub Posted by Ed Jones on Nov 27th, 2019 // Comments off AxoGen (NASDAQ:AXGN) was upgraded by equities research analysts at BidaskClub from a “strong sell” rating … buy” rating in a research report on Thursday, August 1st. William Blair downgraded AxoGen from an “outperform” rating to a “market perform” rating in a research report on Wednesday, August 7th. Cantor Fitzgerald reduced their …

Grand Canyon Education (NASDAQ:LOPE) Lowered to Hold at Zacks Investment Research - Modern Readers | 11/16/2019

Grand Canyon Education (NASDAQ:LOPE) Lowered to Hold at Zacks Investment Research Posted by Ed Jones on Nov 16th, 2019 // Comments off Zacks Investment Research downgraded shares of Grand Canyon Education (NASDAQ:LOPE) from a … have recently made changes to their positions in the company. William Blair Investment Management LLC boosted its stake in shares of Grand Canyon Education by 30.9% in the 2nd quarter. William Blair Investment Management LLC …

Peter Gassner

Veeva Systems Inc (VEEV) Q3 2020 Earnings Call Transcript | The Motley Fool | 11/27/2019

… Veeva’s fiscal 2020 third quarter earnings call for the quarter ended October 31, 2019. With me on today’s call are Peter Gassner, our Chief Executive Officer; Paul Shawah, SVP of Commercial Cloud; and Tim Cabral … guys. Operator Your next question is from Bhavan Suri with William Blair. Your line is open. Bhavan Suri – William Blair – Analyst Thanks for taking my questions, guys, and nice job there. I wanted to follow …

Veeva Systems Inc. (VEEV) CEO Peter Gassner on Fiscal Q1 2020 Results - Earnings Call Transcript | Seeking Alpha | 5/30/2019

Veeva Systems Inc. (NYSE: VEEV ) Q1 2020 Results Earnings Conference Call May 29, 2019 4:30 PM Rick Lund - Investor Relations Director Peter Gassner - Chief Executive Officer Tim Cabral - Chief Financial Officer Matt Wallach - President Paul Shawah - Vice President, Commercial Cloud Strategy Tom Roderick - Stifel, Nicolaus & Co., Inc. Kenneth Wong - Guggenheim Partners Bhavan Suri - William Blair & Company Jackson Ader - J.P. Morgan Scott Berg - Needham & Company Stan Zlotsky - Morgan Stanley James Rutherford …

Chris Tofalli

The Jordan Company Acquires PSG’s Polymer Additives Division from Arsenal Capital Partners | PR Newswire | 11/26/2019

… Materials Division will remain with Arsenal. The Functional Materials Division is headquartered in Calhoun, Georgia . Lazard Middle Market LLC and William Blair & Co. advised PSG and Arsenal. About PSG Polymer Additives PSG Polymer Additives is … thejordancompany.com PSG — Christine Dunlop , Marketing Communications Specialist, [email protected] Arsenal — Chris Tofalli , Chris Tofalli Public Relations, LLC, [email protected] SOURCE Arsenal Capital Partners Related Links http://www.arsenalcapital.com …

Tim Lugo

Analysts Are Bullish on These Healthcare Stocks: Ovid Therapeutics (OVID), Pieris Pharmaceuticals (PIRS) | 11/22/2019

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ovid Therapeutics ( OVID – Research Report ) and Pieris Pharmaceuticals ( PIRS – Research Report ) with bullish sentiments. Ovid Therapeutics (OVID) In a report issued on November 19, Tim Lugo from William Blair maintained a Buy rating on Ovid Therapeutics. The company’s shares closed last Monday at $2.81. According to TipRanks.com , Lugo is a 4-star …

BioMarin Pharmaceutical (BMRN) Receives a Buy from William Blair | 11/15/2019

BioMarin Pharmaceutical (BMRN) Receives a Buy from William Blair Carrie Williams - November 15, 2019, 11:01 AM EDT SHARE ON: In a report released today, Tim Lugo from William Blair maintained a Buy rating on BioMarin Pharmaceutical ( BMRN ). The company’s shares closed last Monday at $75.41. According to TipRanks.com , Lugo is a 4-star analyst with an average return of 8.6% and a 42.9% success rate. Lugo covers the Healthcare sector …

Caroline Luz

Harvest Partners Announces Acquisition of Service Express | PR Newswire | 11/22/2019

… excellence, and we are thrilled to be partners with the Company through its next chapter of growth.” Rothschild & Co and William Blair served as financial advisors and Alston & Bird LLP served as legal advisor to … oriented growth companies. For more information, please visit www.harvestpartners.com . Contact: Caroline Luz Blicksilver PR 203-656-2829 [email protected] SOURCE Harvest Partners …

Harvest Partners Announces Acquisition of Yellowstone Landscape | PR Newswire | 11/1/2019

… Williams served as financial advisor and Kirkland & Ellis LLP served as legal advisor to CIVC and Yellowstone. Piper Jaffray and William Blair acted as financial advisors to Harvest Partners. Harvest Partners’ legal advisor was Ropes … oriented growth companies. For more information, please visit www.harvestpartners.com . Contact: Caroline Luz Blicksilver PR 203-656-2829 [email protected] SOURCE Harvest Partners, LP Related Links http://www.harvestpartners.com …

Sean Wieland

Health Catalyst Inc (HCAT) Q3 2019 Earnings Call Transcript | The Motley Fool | 11/13/2019

… Jones – Goldman Sachs – Analyst Very helpful. Thanks so much. Operator Thank you. Our next question comes from Ryan Daniels with William Blair. Your line is now open. Jared Haase – William Blair – Analyst Yes. Hi, this … Thank you. Operator Thank you. Our next question comes from Sean Wieland with Piper Jaffray. Your line is now open. Sean Wieland – Piper Jaffray – Analyst Hi, thanks. I wanted to ask about the launch of …

Health Catalyst, Inc.’s (HCAT) CEO Dan Burton on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/13/2019

Health Catalyst, Inc. (NASDAQ: HCAT 5:00 Adam Brown - Senior Vice President, Investor Relations Dan Burton - Chief Executive Officer Patrick Nelli - Chief Financial Anne Samuel - JP Morgan Robert Jones - Goldman Sachs Jared Hasse - William Blair Sean Wieland - Piper Jaffray Michael Newshel - Evercore Daniel Grosslight - SVB Leerink Operator Ladies and gentlemen, thank you for standing by and welcome to the Health Catalyst Incorporated Conference Call. At this time, all participants are in …

Donato Tramuto

Tivity Health, Inc. (TVTY) CEO Donato Tramuto on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/13/2019

Tivity Health, Inc. (NASDAQ: TVTY ) Q3 2019 Earnings Conference Call November 12, 2019 5:00 PM ET Company Participants Donato Tramuto - CEO & Director Dawn Zier - President, COO & Director Adam Holland - CFO Steven Janicak - President, Fitness Division & Division President of Healthcare Conference Call Participants Alex Fuhrman - Craig-Hallum David MacDonald - SunTrust Robinson Humphrey David Styblo - Jefferies Nicholas Spiekhout - William Blair & Company Operator Good afternoon, and welcome to the Tivity Health Third Quarter …

Tivity Health, Inc. (TVTY) Q2 2019 Earnings Call Transcript - Nasdaq.com | 8/12/2019

… events or otherwise. And now I would like to turn the call over to the company’s Chief Executive Officer, Mr. Donato Tramuto. You may begin, sir. Donato J. Tramuto – Chief Executive Officer Welcome and thank … you. Operator Your next question comes from Ryan Daniels with William Blair. Your line is open. Nicholas Spiekhout – William Blair – Analyst Hey, guys. This is a Nick Spiekhout in for Ryan. Thanks for taking my …

David MacDonald

Tivity Health, Inc. (TVTY) CEO Donato Tramuto on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/13/2019

Tivity Health, Inc. (NASDAQ: TVTY ) Q3 2019 Earnings Conference Call November 12, 2019 5:00 PM ET Company Participants Donato Tramuto - CEO & Director Dawn Zier - President, COO & Director Adam Holland - CFO Steven Janicak - President, Fitness Division & Division President of Healthcare Conference Call Participants Alex Fuhrman - Craig-Hallum David MacDonald - SunTrust Robinson Humphrey David Styblo - Jefferies Nicholas Spiekhout - William Blair & Company Operator Good afternoon, and welcome to the Tivity Health Third Quarter …

Tivity Health, Inc. (TVTY) Q2 2019 Earnings Call Transcript - Nasdaq.com | 8/12/2019

… starts. Alex Fuhrman – Craig-Hallum – Analyst Okay, that’s helpful. Thank you. Operator Your next question comes from Ryan Daniels with William Blair. Your line is open. Nicholas Spiekhout – William Blair – Analyst Hey, guys. This is … you taking my questions. Operator Your next question comes from David Macdonald of SunTrust. Please go ahead. Your line is open. David Macdonald – SunTrust – Analyst Good afternoon, everyone. Donato, just a quick question, just to …